Proactive Investors - Run By Investors For Investors

Deltex Medical wins largest NHS order for two years

The hospital in the south-east of England has bought six CardioQ-ODM+ monitors and oesophageal probes
picture of surgeons working
NHS work is picking up again suggests Deltex

Deltex Medical Group plc (LON:DEMG) has won its most significant order from a NHS hospital for Oesophageal Doppler Monitoring equipment for over two years.

The hospital in the south-east of England has bought six CardioQ-ODM+ monitors and oesophageal probes in a  purchase worth £30,000.

Its doctors demanded a replacement to equipment bought in 2013 through a NHS national  programme.

While the order was not large enough to affect forecasts this year, it does reflect a generally improving UK performance in the second half of the year to date said Deltex.

Ewan Phillips chief executive, said it was encouraging that it was doctors insisting on its equipment.

Deltex has been hard hit by the cash crisis affecting the NHS but Phillips said today’s order was further evidence that, for the company anyway, the situation may be improving.

“Excellent results from the largest ever randomised controlled trial of ODM in June and the further presentation in July of a trial from a major NHS hospital confirming better comparative outcomes from using ODM during surgery," had also boosted sentiment, he added.

View full DEMG profile View Profile

Deltex Medical Group plc Timeline

May 31 2017

Related Articles

December 03 2018
Since September, the group's portfolio has steamed ahead with a number of new and successful clinical trials, as well as a boost from the float of one of its companies on the Nasdaq
April 02 2019
Geremy Thomas, founder and chief executive of Sativa, said the company has made significant progress since it started trading on NEX.
Social media use
Social first has allowed sites like UNILAD to amass a huge audience with very little capital injection, but what is social first publishing and how is it changing the nature of content and advertising?

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use